National Institute of Allergy and Infectious Diseases
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

HIV/AIDS
 Understanding
 Research
  Research Overview
  Basic Science
  Epidemiology
  Prevention
  Therapeutics
  Vaccines
   Introduction and Goals
   Research Activities
   Resources for Researchers
   Funding
   Meetings
   Reports and Articles
   Advisory and Working Groups
   Clinical Trials
   Considerations Papers
   Education and Outreach
  Clinical Research
  Advisory Groups and Committees
  Partners and Collaborators
  Funding Opportunities


HIV/AIDS

Resources for Researchers

Research

Development

Critical Path Resources available to advance candidates into Phase I trials.

back to top

Highlights

Bulletin: HVTN 505 HIV Vaccine Study Begins Enrolling Volunteers—Aug. 24, 2009

Q&A: The HVTN 505 HIV Vaccine Regimen Study—Aug. 24, 2009

See Also

  • Division of AIDS
  • Vaccine Research Center
  • HIV/AIDS Publications
  • HIV/AIDS News Releases
  • Global Research, Africa
  • Selected NIAID Science Advances, 2007-2008 (PDF)
  • Vaccines
  • NIAID Funding News

  • Highlights

    Bulletin: HVTN 505 HIV Vaccine Study Begins Enrolling Volunteers—Aug. 24, 2009

    Q&A: The HVTN 505 HIV Vaccine Regimen Study—Aug. 24, 2009

    See Also

  • Division of AIDS
  • Vaccine Research Center
  • HIV/AIDS Publications
  • HIV/AIDS News Releases
  • Global Research, Africa
  • Selected NIAID Science Advances, 2007-2008 (PDF)
  • Vaccines
  • NIAID Funding News